科普專欄–薯不揀單 - 深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)

上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1411Please respect copyright.ＰＥＮＡＮＡH3mFIrytnq
1411Please respect copyright.ＰＥＮＡＮＡZGRn5pFvc9
上集：https://www.penana.com/article/4711251411Please respect copyright.ＰＥＮＡＮＡimAlsqueZr
1411Please respect copyright.ＰＥＮＡＮＡtgI0neia3U
1411Please respect copyright.ＰＥＮＡＮＡ6rNxN12zOY
1411Please respect copyright.ＰＥＮＡＮＡZ1rqE3N8u0
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1411Please respect copyright.ＰＥＮＡＮＡjT7qzeFkmS
1411Please respect copyright.ＰＥＮＡＮＡzBm0lsWqzs
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1411Please respect copyright.ＰＥＮＡＮＡCtonXcC18r
1411Please respect copyright.ＰＥＮＡＮＡU5KEGwpLQM
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1411Please respect copyright.ＰＥＮＡＮＡnDDGA1spov
1411Please respect copyright.ＰＥＮＡＮＡhNCWRDy6Nc
1411Please respect copyright.ＰＥＮＡＮＡNpb40pcRqa
1411Please respect copyright.ＰＥＮＡＮＡckAyaW8PEq
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1411Please respect copyright.ＰＥＮＡＮＡYKxHdhrJ30
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1411Please respect copyright.ＰＥＮＡＮＡArudPPcZ2p
1411Please respect copyright.ＰＥＮＡＮＡZsYcW3BGAI
忘記甚麼是Neoantigen的話，可重溫上一集。1411Please respect copyright.ＰＥＮＡＮＡKJeQ9nnqku
1411Please respect copyright.ＰＥＮＡＮＡvub31cId3j
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1411Please respect copyright.ＰＥＮＡＮＡoaWki1sC6H
1411Please respect copyright.ＰＥＮＡＮＡmOPjDhipyu
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1411Please respect copyright.ＰＥＮＡＮＡoy9rj0FUZ9
1411Please respect copyright.ＰＥＮＡＮＡN1Ir9OPIOK
1411Please respect copyright.ＰＥＮＡＮＡOOqtUSMjQk
1411Please respect copyright.ＰＥＮＡＮＡtxkq9WjxIe
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1411Please respect copyright.ＰＥＮＡＮＡTAwJo1QPkF
1411Please respect copyright.ＰＥＮＡＮＡgs6bYYMr7K
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1411Please respect copyright.ＰＥＮＡＮＡJAUn6ox8sy
1411Please respect copyright.ＰＥＮＡＮＡJ9WC4Tu2F6
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1411Please respect copyright.ＰＥＮＡＮＡEu9BT5DBef
1411Please respect copyright.ＰＥＮＡＮＡvIwqi8AakW
1411Please respect copyright.ＰＥＮＡＮＡBNfNOF8P4S
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1411Please respect copyright.ＰＥＮＡＮＡnBBK33Upy7
1411Please respect copyright.ＰＥＮＡＮＡYM9JXnGl0I
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1411Please respect copyright.ＰＥＮＡＮＡteUpVbWZtc
1411Please respect copyright.ＰＥＮＡＮＡ0jySKP9qI8
1411Please respect copyright.ＰＥＮＡＮＡqJzTIluBz2
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1411Please respect copyright.ＰＥＮＡＮＡNjbBXZFKr1
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1411Please respect copyright.ＰＥＮＡＮＡ2hb2V9fep6
1411Please respect copyright.ＰＥＮＡＮＡPjtYdxmtgJ
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1411Please respect copyright.ＰＥＮＡＮＡxOSPflo6Yq
1411Please respect copyright.ＰＥＮＡＮＡJ7atuIx3DI
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1411Please respect copyright.ＰＥＮＡＮＡ0dXX4gwVgC
1411Please respect copyright.ＰＥＮＡＮＡX7YlVrF3du
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1411Please respect copyright.ＰＥＮＡＮＡENAjnH5zB0
1411Please respect copyright.ＰＥＮＡＮＡ6VasmV6CdF
1411Please respect copyright.ＰＥＮＡＮＡe0c7xF8AGA
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1411Please respect copyright.ＰＥＮＡＮＡWHz7XAjb4r
1411Please respect copyright.ＰＥＮＡＮＡdAMjBvX5WZ
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1411Please respect copyright.ＰＥＮＡＮＡwu0vdhMjAW
1411Please respect copyright.ＰＥＮＡＮＡSCAPYbsrtk
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1411Please respect copyright.ＰＥＮＡＮＡHEJjwHvTBn
1411Please respect copyright.ＰＥＮＡＮＡ0KNIchXj2U
Link:1411Please respect copyright.ＰＥＮＡＮＡfHICMxejC0
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1411Please respect copyright.ＰＥＮＡＮＡT2ZRXqnKmD
1411Please respect copyright.ＰＥＮＡＮＡp0EtcN9Va1
1411Please respect copyright.ＰＥＮＡＮＡwaESXrrOFQ
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1411Please respect copyright.ＰＥＮＡＮＡBUBj8UE73l